Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WHI-P233, a new cytotoxic melamine derivative

Feb. 8, 2001

Progen concludes phase Ib evaluation of PI-88

Feb. 8, 2001

Novel fluoroindolocarbazoles formed in rebeccamycin-producing microorganism

Feb. 8, 2001

Isolation, structure determination and cytotoxic activity of AJI-9561

Feb. 8, 2001

Novel DNA crosslinker with potential in the treatment of cisplatin-resistant ovarian cancer

Feb. 8, 2001

Phase II study examines IMC-C225 in combination with other agents for NSCLC

Feb. 8, 2001

NewBiotics and Elan form joint venture to develop colon cancer therapy

Feb. 8, 2001

Japanese labs design new series of ribonucleotide reductase inhibitors

Feb. 7, 2001

YM BioSciences extends EGF cancer vaccine trial to include U.K. sites

Feb. 7, 2001

Results with INGN-201 indicate new strategy for cancer immunotherapy

Feb. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...